KCa3.1 INHIBITORS FOR PODOCYTE PROTECTION
US-2024391880-A1 · Nov 28, 2024 · US
Composition for preventing or improving impaired renal function, pharmaceutical composition, food/beverage composition, and method of preventing or improving impaired renal function using the composition for preventing or improving impaired renal function
US11045508B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11045508-B2 |
| Application number | US-201916394330-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 25, 2019 |
| Priority date | Apr 25, 2019 |
| Publication date | Jun 29, 2021 |
| Grant date | Jun 29, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided is a composition for preventing or improving impaired renal function, containing Bifidobacterium breve as an active ingredient. The composition for preventing or improving impaired renal function is capable of reducing blood creatinine levels. The composition for preventing or improving impaired renal function can also be used in a pharmaceutical composition or a food or beverage product composition.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of improving renal function in a subject having impaired renal function, the method comprising administering Bifidobacterium breve to the subject in an amount sufficient to reduce blood creatinine levels. 2. The method according to claim 1 , wherein the Bifidobacterium breve is Bifidobacterium breve MCC1274 (FERM BP-11175). 3. The method of claim 1 , wherein the method also results in improved glomerular function. 4. The method of claim 1 , wherein the Bifidobacterium breve is formulated into a pharmaceutical composition. 5. The method of claim 1 , wherein the Bifidobacterium breve is formulated into a food or beverage product. 6. A method of reducing blood creatinine levels in a subject having impaired renal function, the method comprising administering Bifidobacterium breve to the subject in an amount sufficient to reduce blood creatinine levels. 7. The method according to claim 6 , wherein the Bifidobacterium breve is Bifidobacterium breve MCC1274 (FERM BP-11175). 8. The method of claim 6 , wherein the method also results in improved glomerular function. 9. The method of claim 6 , wherein the Bifidobacterium breve is formulated into a pharmaceutical composition. 10. The method of claim 6 , wherein the Bifidobacterium breve is formulated into a food or beverage product.
Assignees
Inventors
Classifications
Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006) · CPC title
Adding ingredients (adding preservatives A23B70/10) · CPC title
Milk; Whey; Colostrum · CPC title
Bacteria or derivatives thereof, e.g. probiotics · CPC title
Proteins · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11045508B2 cover?
- Provided is a composition for preventing or improving impaired renal function, containing Bifidobacterium breve as an active ingredient. The composition for preventing or improving impaired renal function is capable of reducing blood creatinine levels. The composition for preventing or improving impaired renal function can also be used in a pharmaceutical composition or a food or beverage produ…
- Who is the assignee on this patent?
- Morinaga Milk Industry Co Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61P13/12. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).